1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy
- 1 March 1976
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 1-1 (1-2) , 77-86
- https://doi.org/10.1007/bf00205298
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cell‐mediated immune responsiveness of patients with acute lymphocytic leukemia in remissionInternational Journal of Cancer, 1976
- Surviving in company of BCGCancer Immunology, Immunotherapy, 1976
- The second generation of EORTC-ICIG experimental screening for systemic immunity adjuvants: Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extractPublished by Elsevier ,1975
- CHEMOTHERAPY AND B.C.G. IN ACUTE LYMPHOCYTIC LEUKqMIAThe Lancet, 1975
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemiaPublished by Elsevier ,1974
- PROLONGING REMISSION IN MYELOBLASTIC LEUKÆMIA BY TICE-STRAIN BACILLUS CALMETTE-GUÉRINThe Lancet, 1974
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Treatment of Acute Lymphoblastic Leukaemia: PRELIMINARY REPORT BY THE LEUKAEMIA COMMITTEE AND THE WORKING PARTY ON LEUKAEMIA IN CHILDHOODBMJ, 1971
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969